Adrenocortical Carcinoma: Single Center Experience
European Archives of Medical Research · 2019
DOI: 10.4274/eamr.25744 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Medical Research, 2019. Verfasst von Abdullah Sakin und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
The prevalence of adrenocortical carcinoma(ACC) is approximately 0.02% of all cancers, and the annual incidence is approximately one to two per million population.Adrenocortical carcinoma is more aggressive, and the prognosis of ACC is poorer in adults than pediatric patients.We aimed to investigate the clinicopathologic characteristics and the factors affecting on the overall survival (OS) in patients with ACC who were followedup, and treated in our hospital in the present study.
Methods
The patients who were treated and followed-up in the oncology clinic between 2006-2018 were retrospectivelly included in the study.The patients who were diagnosed with adrenocortical carcinoma in pathologic evaluation were included in the study.
Results
A total of 10 patients, 5(50%) men, and 5(50%) women, were included in the study.The mean age was 42.4 (range, 18-67) years.Six (60%) patients were in stage 3, and 4 (40%) patients were in stage 4. Eight (80%)patients underwent surgery.The release of glucocorticoid and/or androgen was detected in 6(60%) patients.Recurrence developed in 6(100%) patients, and 7 (70%) patients died during the follow-up.The median survival was 13 months in patients with stage 3 disease, and the median survival was 8 months in patients with stage 4 disease.There was no statistically significant survival difference between the stages (Log rank p: 0.177).The Eastern Cooperative Oncology Group Performance Status (ECOG PS), and performing of surgery were detected as the most significant factors affecting the overall survival (Log rank p: 0.01, Log rank p: 0.02).Conclusıon: We detected the statistically most significant factors for OS as the surgery and ECOG PS in our study.The increase of ECOG PS increased the mortality risk four folds.
Zitieren
APA
Sakin, A., Seçmeler, Ş., Can, O., Arıcı, S., Geredeli, Ç., Yaşar, N., Demir, C., & Cihan, Ş. (2019). Adrenocortical Carcinoma: Single Center Experience. European Archives of Medical Research. https://doi.org/10.4274/eamr.25744
Vancouver
Sakin A, Seçmeler Ş, Can O, Arıcı S, Geredeli Ç, Yaşar N, et al. Adrenocortical Carcinoma: Single Center Experience. European Archives of Medical Research. 2019. doi:10.4274/eamr.25744
BibTeX
@article{Sakin2019,
author = {Sakin, Abdullah and Seçmeler, Şaban and Can, Orçun and Arıcı, Serdar and Geredeli, Çağlayan and Yaşar, Nurgul and Demir, Cumhur and Cihan, Şener},
title = {Adrenocortical Carcinoma: Single Center Experience},
journal = {European Archives of Medical Research},
year = {2019},
doi = {10.4274/eamr.25744}
}
EUVIMED